{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:05:21Z","timestamp":1790931921586,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["ZXYXZ-2019011"],"award-info":[{"award-number":["ZXYXZ-2019011"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["21ZR1457100"],"award-info":[{"award-number":["21ZR1457100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31801187"],"award-info":[{"award-number":["31801187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073013"],"award-info":[{"award-number":["82073013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.pdpdt.2021.102572","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T08:23:52Z","timestamp":1633767832000},"page":"102572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC"],"prefix":"10.1016","volume":"37","author":[{"given":"Ting","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2021.102572_bib0001","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Burden of Disease","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0003","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pdpdt.2008.05.003","article-title":"Treatment of skin cancer and pre-cancer using topical ALA-PDT\u2013a single hospital experience","volume":"5","author":"Wang","year":"2008","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jdv.12258","article-title":"European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544","volume":"28","author":"Skaria","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8100090","article-title":"Photodynamic therapy for non-melanoma skin cancers","volume":"8","author":"Cohen","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pdpdt.2021.102572_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101980","article-title":"Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: single center experience","volume":"32","author":"Zhang","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0008","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2018.10.042","article-title":"Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma","volume":"80","author":"Keyal","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pdpdt.2017.12.010","article-title":"Successful treatment of giant invasive cutaneous squamous cell carcinoma by plum-blossom needle assisted photodynamic therapy sequential with imiquimod: case experience","volume":"21","author":"Wang","year":"2018","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0010","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2014.178","article-title":"Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy","volume":"134","author":"Gilaberte","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0011","doi-asserted-by":"crossref","first-page":"f6153","DOI":"10.1136\/bmj.f6153","article-title":"Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies","volume":"347","author":"Lansbury","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pdpdt.2021.102572_bib0012","doi-asserted-by":"crossref","first-page":"14778","DOI":"10.3748\/wjg.v20.i40.14778","article-title":"Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract","volume":"20","author":"Pines","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0013","doi-asserted-by":"crossref","first-page":"86447","DOI":"10.18632\/oncotarget.21200","article-title":"Halofuginone inhibits TGF-beta\/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis","volume":"8","author":"Juarez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pdpdt.2021.102572_bib0014","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.12.041","article-title":"Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation","volume":"103","author":"Tsuchida","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/17460441.3.1.11","article-title":"Targeting TGFbeta signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone","volume":"3","author":"Pines","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0016","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.bmc.2014.02.040","article-title":"The chemistry and biology of febrifugine and halofuginone","volume":"22","author":"McLaughlin","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/jb\/mvab025","article-title":"Targeting Nrf2-antioxidant signaling reverses acquired cabazitaxel resistance in prostate cancer cells","author":"Endo","year":"2021","journal-title":"J. Biochem."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0018","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","article-title":"NRF2 and cancer: the good, the bad and the importance of context","volume":"12","author":"Sporn","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pdpdt.2021.102572_bib0019","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1007\/s00018-015-1976-1","article-title":"Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells","volume":"72","author":"Zeng","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.det.2006.09.012","article-title":"Incorporating photodynamic therapy into a medical and cosmetic dermatology practice","volume":"25","author":"Gilbert","year":"2007","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14357","article-title":"5-Aminolaevulinic acid photodynamic therapy amplifies intense inflammatory response in the treatment of acne vulgaris via CXCL8","author":"Zhang","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111672","article-title":"The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: implications for photodynamic therapy","volume":"202","author":"Ferino","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2021.102572_bib0028","first-page":"1824","article-title":"Enhancement of the effect of methyl pyropheophorbide-a-mediated photodynamic therapy was achieved by increasing ROS through inhibition of Nrf2-HO-1 or Nrf2-ABCG2 signaling","volume":"17","author":"Tian","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0029","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pdpdt.2019.05.006","article-title":"Effects of low-dose ALA-PDT on fibroblast photoaging induced by UVA irradiation and the underlying mechanisms","volume":"27","author":"Chen","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0031","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1111\/jcmm.13628","article-title":"Nrf2 attenuates inflammatory response in COPD\/emphysema: crosstalk with Wnt3a\/beta-catenin and AMPK pathways","volume":"22","author":"Cui","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2432416","article-title":"Sesamin enhances Nrf2-mediated protective defense against oxidative stress and inflammation in colitis via AKT and ERK activation","author":"Bai","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.pdpdt.2021.102572_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113285","article-title":"Crosstalk between the mTOR and Nrf2\/ARE signaling pathways as a target in the improvement of long-term potentiation","volume":"328","author":"Gureev","year":"2020","journal-title":"Exp. Neurol."}],"updated-by":[{"DOI":"10.1016\/j.pdpdt.2025.104657","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:41:20Z","timestamp":1761612080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S1572100021003951"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102572","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102572"}}